Amphastar Pharmaceuticals (AMPH) Deferred Taxes (2013 - 2021)

Amphastar Pharmaceuticals' Deferred Taxes history runs 5 years deep, the most recent figure standing at $2.8 million for Q4 2021.

• In Q4 2021, Deferred Taxes fell 26.79% year-over-year to $2.8 million; the TTM figure through Dec 2021 stood at $4.6 million (up 2728.4% YoY), while the FY2025 annual figure was -$28.7 million, down 260.36% from the prior year.
• Deferred Taxes was $2.8 million for Q4 2021 at Amphastar Pharmaceuticals, down from $3.8 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $5.3 million in Q4 2019 to a low of -$2.0 million in Q3 2020.
• Historically, Deferred Taxes has averaged $1.7 million across 3 years, with a median of $2.8 million in 2021.
• The sharpest annual moves came in 2020 and 2021: Deferred Taxes declined 28.71% in 2020, then declined 26.79% in 2021.
• A 3-year view of Deferred Taxes shows it stood at $5.3 million in 2019, then slipped by 28.71% to $3.8 million in 2020, then decreased by 26.79% to $2.8 million in 2021.
• The last three Deferred Taxes figures came in at $2.8 million (Q4 2021), $3.8 million (Q4 2020), and -$2.0 million (Q3 2020), per Business Quant data.